PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 95 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $9,140,000 | +34.6% | 2,268,000 | +44.3% | 0.53% | +17.1% |
| Q3 2019 | $6,791,000 | -31.3% | 1,572,000 | -36.6% | 0.45% | -27.8% |
| Q2 2019 | $9,887,000 | -13.2% | 2,478,000 | +16.7% | 0.62% | 0.0% |
| Q1 2019 | $11,385,000 | +12.8% | 2,124,000 | +7.9% | 0.62% | -18.6% |
| Q4 2018 | $10,096,000 | -13.3% | 1,968,000 | +64.0% | 0.76% | +9.4% |
| Q3 2018 | $11,640,000 | +0.8% | 1,200,000 | +6.0% | 0.70% | -7.3% |
| Q2 2018 | $11,546,000 | +53.1% | 1,132,000 | +95.2% | 0.75% | +30.7% |
| Q1 2018 | $7,540,000 | – | 580,000 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
| Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
| Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
| Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
| 1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
| Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
| Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
| Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
| CM Management, LLC | 200,000 | $972,000 | 0.72% |
| GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |